Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harrow (HROW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Harrow (HROW) over the last 13 years, with Q3 2025 value amounting to $74.3 million.

  • Harrow's Cash & Equivalents rose 232.64% to $74.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.3 million, marking a year-over-year increase of 232.64%. This contributed to the annual value of $47.2 million for FY2024, which is 3622.6% down from last year.
  • Harrow's Cash & Equivalents amounted to $74.3 million in Q3 2025, which was up 232.64% from $53.0 million recorded in Q2 2025.
  • Harrow's 5-year Cash & Equivalents high stood at $96.3 million for Q4 2022, and its period low was $6.5 million during Q1 2021.
  • For the 5-year period, Harrow's Cash & Equivalents averaged around $54.9 million, with its median value being $57.9 million (2021).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 167598.73% in 2021, then crashed by 5411.46% in 2023.
  • Over the past 5 years, Harrow's Cash & Equivalents (Quarter) stood at $42.2 million in 2021, then surged by 128.31% to $96.3 million in 2022, then decreased by 23.04% to $74.1 million in 2023, then crashed by 36.23% to $47.2 million in 2024, then skyrocketed by 57.24% to $74.3 million in 2025.
  • Its Cash & Equivalents stands at $74.3 million for Q3 2025, versus $53.0 million for Q2 2025 and $66.7 million for Q1 2025.